BetterLife Pharma Earnings Per Share vs. Total Asset

BETRF Stock  USD 0.08  0.01  9.59%   
Based on the key profitability measurements obtained from BetterLife Pharma's financial statements, BetterLife Pharma may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess BetterLife Pharma's ability to earn profits and add value for shareholders.
For BetterLife Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BetterLife Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BetterLife Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BetterLife Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BetterLife Pharma over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between BetterLife Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if BetterLife Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BetterLife Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BetterLife Pharma Total Asset vs. Earnings Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BetterLife Pharma's current stock value. Our valuation model uses many indicators to compare BetterLife Pharma value to that of its competitors to determine the firm's financial worth.
BetterLife Pharma is number one stock in earnings per share category among its peers. It also is number one stock in total asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BetterLife Pharma's earnings, one of the primary drivers of an investment's value.

BetterLife Total Asset vs. Earnings Per Share

Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

BetterLife Pharma

Earnings per Share

 = 

Earnings

Average Shares

 = 
(0.12) X
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

BetterLife Pharma

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
1.16 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

BetterLife Total Asset Comparison

BetterLife Pharma is currently under evaluation in total asset category among its peers.

BetterLife Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BetterLife Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BetterLife Pharma will eventually generate negative long term returns. The profitability progress is the general direction of BetterLife Pharma's change in net profit over the period of time. It can combine multiple indicators of BetterLife Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Betterlife Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.

BetterLife Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BetterLife Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BetterLife Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BetterLife Pharma's important profitability drivers and their relationship over time.

Use BetterLife Pharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BetterLife Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BetterLife Pharma will appreciate offsetting losses from the drop in the long position's value.

BetterLife Pharma Pair Trading

BetterLife Pharma Pair Trading Analysis

The ability to find closely correlated positions to BetterLife Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BetterLife Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BetterLife Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BetterLife Pharma to buy it.
The correlation of BetterLife Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BetterLife Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BetterLife Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BetterLife Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BetterLife Pharma position

In addition to having BetterLife Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electronics Thematic Idea Now

Electronics
Electronics Theme
Companies manufacturing electronic appliances and goods. The Electronics theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronics Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in BetterLife OTC Stock

To fully project BetterLife Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BetterLife Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BetterLife Pharma's income statement, its balance sheet, and the statement of cash flows.
Potential BetterLife Pharma investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although BetterLife Pharma investors may work on each financial statement separately, they are all related. The changes in BetterLife Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BetterLife Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.